Insiders Trades

★ Sign in to follow

JR

Joseph Roderick Matheson

Shareholder

Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

Insider activity · 24 months27 buys0 salesCumulative net flow

Nov 24 · 1 buy · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 1 buy · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 2 buys · 0 salesJun 25 · 4 buys · 0 salesJul 25 · 7 buys · 0 salesAug 25 · 9 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 1 buy · 0 salesNov 25 · 1 buy · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 1 buy · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

49

Company

1

▲ Purchases (40 ops.)

€121k

▼ Sales (0 ops.)

—

Latest filing published 20 Aug 2026 for Marvel Biosciences Corp. Formerly Alphanco Venture Corp., €61k.

Filing timeline

BuySale

Joseph Roderick Matheson

Insider track record

Disclosed buys

40

Disclosed sells

0

Signal history

Joseph Roderick Matheson: trading record in brief

Joseph Roderick Matheson appears in our data through filings on Marvel Biosciences Corp. Formerly Alphanco Venture Corp. shares, published by SEDI. Between 14 June 2021 and 19 August 2026, the trades on record add up to 49 filings.

Purchases make up the whole of the open-market record (40 purchases, €121k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €2,656 and half below. Across 38 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The record was last updated on 20 August 2026 with a transaction (€61k) in Marvel Biosciences Corp. Formerly Alphanco Venture Corp. The last insider purchase was made public on 14 August 2026, 71 days ago. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to Joseph Roderick Matheson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Marvel Biosciences Corp. Formerly Alphanco Venture Corp. (CA)

Declarations49 total

●

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives19 Aug 2026Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

99,000 CAD32SEDI

600,000 shares@ CA$0.1651.05% mcap95.2% of flowCommon SharesTSXSEDI:4766654

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Aug 2026Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

4,950 CAD15SEDI

30,000 shares@ CA$0.1650.053% mcap4.8% of flowCommon SharesTSXSEDI:4764733

Canonical exit: 12 Nov 2026 (T+90)

●

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives24 Feb 2026Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

0SEDI

4,166,667 sharesCommon SharesTSXSEDI:4704553

●

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives24 Feb 2026Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

0SEDI

4,166,667 sharesCommon SharesTSXSEDI:4704552

●

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives24 Feb 2026Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

500,000 CAD23SEDI

4,166,667 shares@ CA$0.1259.3% of flowCommon SharesTSXSEDI:4667359

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Nov 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

1,100 CAD13SEDI

5,500 shares@ CA$0.200.9% of flowCommon SharesTSXSEDI:4604500

Canonical exit: 10 Feb 2026 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Oct 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

11,515 CAD12SEDI

49,000 shares@ CA$0.2359.3% of flowCommon SharesTSXSEDI:4591725

Canonical exit: 12 Jan 2026 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives28 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

4,800 CAD17SEDI

20,000 shares@ CA$0.242.0% of flowCommon SharesTSXSEDI:4566782

Canonical exit: 26 Nov 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives28 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

2,350 CAD17SEDI

10,000 shares@ CA$0.2351.0% of flowCommon SharesTSXSEDI:4566781

Canonical exit: 26 Nov 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

6,965 CAD17SEDI

35,000 shares@ CA$0.1992.9% of flowCommon SharesTSXSEDI:4561595

Canonical exit: 13 Nov 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives13 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

1,900 CAD17SEDI

10,000 shares@ CA$0.190.8% of flowCommon SharesTSXSEDI:4560341

Canonical exit: 11 Nov 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

3,760 CAD17SEDI

20,000 shares@ CA$0.1881.6% of flowCommon SharesTSXSEDI:4560057

Canonical exit: 10 Nov 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives12 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

7,600 CAD17SEDI

40,000 shares@ CA$0.193.2% of flowCommon SharesTSXSEDI:4560058

Canonical exit: 10 Nov 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives6 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

4,250 CAD17SEDI

25,000 shares@ CA$0.171.8% of flowCommon SharesTSXSEDI:4556102

Canonical exit: 4 Nov 2025 (T+90)

●

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives14 Jun 2021Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

0SEDI

Common SharesTSXSEDI:4553188

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

1,800 CAD17SEDI

10,000 shares@ CA$0.180.8% of flowCommon SharesTSXSEDI:4553190

Canonical exit: 30 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives1 Aug 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

4,500 CAD17SEDI

25,000 shares@ CA$0.181.9% of flowCommon SharesTSXSEDI:4553183

Canonical exit: 30 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

2,240 CAD17SEDI

14,000 shares@ CA$0.161.0% of flowCommon SharesTSXSEDI:4553189

Canonical exit: 27 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives30 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

5,565 CAD17SEDI

35,000 shares@ CA$0.1592.4% of flowCommon SharesTSXSEDI:4552266

Canonical exit: 28 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives29 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

960 CAD17SEDI

6,000 shares@ CA$0.160.4% of flowCommon SharesTSXSEDI:4551818

Canonical exit: 27 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives16 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

1,850 CAD17SEDI

10,000 shares@ CA$0.1850.8% of flowCommon SharesTSXSEDI:4548212

Canonical exit: 14 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives15 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

3,800 CAD17SEDI

20,000 shares@ CA$0.191.6% of flowCommon SharesTSXSEDI:4547626

Canonical exit: 13 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives9 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

9,350 CAD17SEDI

55,000 shares@ CA$0.174.0% of flowCommon SharesTSXSEDI:4545739

Canonical exit: 7 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives4 Jul 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

4,250 CAD17SEDI

25,000 shares@ CA$0.171.8% of flowCommon SharesTSXSEDI:4541642

Canonical exit: 2 Oct 2025 (T+90)

▲

Joseph Roderick Matheson

3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of IssuerExecutives30 Jun 2025Marvel Biosciences Corp. Formerly Alphanco Venture Corp.

1,650 CAD17SEDI

10,000 shares@ CA$0.1650.7% of flowCommon SharesTSXSEDI:4536742

Canonical exit: 28 Sept 2025 (T+90)

25 of 49 declarations